Katharina Willuweit Selected Research

Katharina Willuweit Research Topics

6	Liver Cirrhosis (Hepatic Cirrhosis) 04/2022 - 01/2019
4	Infections 06/2021 - 01/2017
3	Fibrosis (Cirrhosis) 08/2020 - 03/2017
2	Virus Diseases (Viral Diseases) 01/2019 - 01/2017
2	Chronic Hepatitis C 01/2019 - 01/2017
1	Ascites 04/2022
1	Portal Hypertension 04/2022
1	Hepatocellular Carcinoma (Hepatoma) 12/2021
1	Sclerosing Cholangitis 06/2021
1	Cytomegalovirus Infections (Inclusion Disease) 06/2021
1	Diabetes Mellitus 07/2019
1	End Stage Liver Disease 05/2019
1	Inflammation (Inflammations) 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Shock 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Sepsis (Septicemia) 01/2019
1	Vasoplegia 01/2019
1	Reinfection 03/2017

2	AntibodiesIBA 02/2022 - 08/2020
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2019
2	SofosbuvirIBA 03/2017 - 01/2017
1	VaccinesIBA 02/2022
1	Messenger RNA (mRNA)IBA 02/2022
1	Immunoglobulin G (IgG)IBA 02/2022
1	BNT162 VaccineIBA 02/2022
1	Nucleic AcidsIBA 06/2021
1	Everolimus FDA Link 07/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	grazoprevirIBA 01/2019
1	ProcalcitoninIBA 01/2019
1	MTOR InhibitorsIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019
1	Hemostatics (Antihemorrhagics)IBA 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019
1	elbasvirIBA 01/2019
1	Ribavirin (Virazole)FDA LinkGeneric 03/2017
1	InterferonsIBA 03/2017
1	ledipasvirIBA 01/2017

9	Liver Transplantation 04/2022 - 03/2017
3	Therapeutics 04/2022 - 01/2017
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 04/2022 - 01/2021
2	Transjugular Intrahepatic Portasystemic Shunt 04/2022 - 01/2021
2	Transplantation 01/2019 - 01/2017
1	Contraindications 01/2017